NIH-funded research R21 grant

Investigating how mitochondrial dysfunction affects autism spectrum disorder-related genes and brain function

Official title: Resolving the relationship between mitochondrial dysfunction and the impact of non-syndromic autism spectrum disorder-related risk genes on neuronal structure and function

Funded at Icahn School of Medicine at Mount Sinai · NIH-10786441 · Data updated 2026-11-12

This study is looking at how certain genetic changes related to autism might affect brain cells and their connections, using special lab techniques to create and observe brain-like structures, so we can learn more about what happens in autism.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startApril 10, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$253,500
NIH project number1R21HD113986-01
Project IDNIH-10786441 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with non-syndromic autism spectrum disorder, particularly those with genetic variants in the PPP2R5D, SHANK3, or GRIN2B genes.

Less likely to help

Patients without a diagnosis of autism spectrum disorder or those not carrying the relevant genetic variants may not benefit from this research.

What this research studies

This research explores the connection between mitochondrial dysfunction and autism spectrum disorder (ASD) by examining how specific genetic variants impact neuronal structure and function. The study employs innovative techniques, including the creation of induced pluripotent stem cells (iPSCs) with genetic modifications to mimic ASD-related conditions. Researchers will analyze the development of neurons and synaptic connections using advanced imaging methods and 3D brain organoids to better understand the underlying mechanisms of ASD.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the biological mechanisms of autism, potentially informing targeted therapies and interventions.

How similar studies have gone: While the specific 'two-hit' hypothesis is novel, previous research has shown promising results in understanding the genetic and bioenergetic factors contributing to autism.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Kozicz, Laszlo Tamas — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Kozicz, Laszlo Tamas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.